BRPI0818807A2 - METHOD FOR INHIBITING REPERFUSION AND / OR COURSE INJURY IN A PATIENT NEEDING THE SAME AND USING A PLATTER GLYCOPROTEIN VI INHIBITOR - Google Patents

METHOD FOR INHIBITING REPERFUSION AND / OR COURSE INJURY IN A PATIENT NEEDING THE SAME AND USING A PLATTER GLYCOPROTEIN VI INHIBITOR

Info

Publication number
BRPI0818807A2
BRPI0818807A2 BRPI0818807-6A2A BRPI0818807A BRPI0818807A2 BR PI0818807 A2 BRPI0818807 A2 BR PI0818807A2 BR PI0818807 A BRPI0818807 A BR PI0818807A BR PI0818807 A2 BRPI0818807 A2 BR PI0818807A2
Authority
BR
Brazil
Prior art keywords
platter
glycoprotein
inhibitor
same
patient needing
Prior art date
Application number
BRPI0818807-6A2A
Other languages
Portuguese (pt)
Inventor
Yongge Liu
Narendra N Tandon
Hisao Takizawa
Junichi Kambayashi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of BRPI0818807A2 publication Critical patent/BRPI0818807A2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BRPI0818807-6A2A 2007-10-31 2008-10-29 METHOD FOR INHIBITING REPERFUSION AND / OR COURSE INJURY IN A PATIENT NEEDING THE SAME AND USING A PLATTER GLYCOPROTEIN VI INHIBITOR BRPI0818807A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98433407P 2007-10-31 2007-10-31
PCT/US2008/012311 WO2009058326A1 (en) 2007-10-31 2008-10-29 Uses of a glycoprotein vi (gpvi) inhibitor

Publications (1)

Publication Number Publication Date
BRPI0818807A2 true BRPI0818807A2 (en) 2014-10-29

Family

ID=40591365

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0818807-6A2A BRPI0818807A2 (en) 2007-10-31 2008-10-29 METHOD FOR INHIBITING REPERFUSION AND / OR COURSE INJURY IN A PATIENT NEEDING THE SAME AND USING A PLATTER GLYCOPROTEIN VI INHIBITOR

Country Status (16)

Country Link
US (1) US20100297116A1 (en)
EP (1) EP2212416A4 (en)
JP (1) JP2011502123A (en)
KR (1) KR20100075585A (en)
CN (1) CN101874107A (en)
AR (1) AR069120A1 (en)
AU (1) AU2008319336A1 (en)
BR (1) BRPI0818807A2 (en)
CA (1) CA2703770A1 (en)
IL (1) IL205453A0 (en)
MX (1) MX2010004537A (en)
RU (1) RU2010121878A (en)
SG (1) SG185307A1 (en)
TW (1) TW200936606A (en)
WO (1) WO2009058326A1 (en)
ZA (1) ZA201002990B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2336188A1 (en) * 2009-12-18 2011-06-22 Sanofi-Aventis Novel antagonist antibodies and their Fab fragments against GPVI and uses thereof
JP5843783B2 (en) 2009-12-18 2016-01-13 サノフイ Novel antagonist antibody against GPVI, Fab fragment of the antibody and use thereof
EP2397495A1 (en) * 2010-06-21 2011-12-21 Sanofi Novel antagonist antibodies and their Fab fragments against GPVI and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK15762001A3 (en) * 1999-05-07 2002-04-04 Merck Patent Gmbh Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use
US20040001826A1 (en) * 1999-06-30 2004-01-01 Millennium Pharmaceuticals, Inc. Glycoprotein VI and uses thereof
AU7097400A (en) * 1999-09-01 2001-03-26 Otsuka Pharmaceutical Co., Ltd. Platelet membrane glycoprotein vi (gpvi) dna and protein sequences, and uses thereof
EP1224942A1 (en) * 2001-01-23 2002-07-24 Bernhard Dr. Nieswandt Use of JAQ1 (monoclonal antibody anti GPVI) as a medicament for the protection against thrombotic diseases
GB0130543D0 (en) * 2001-12-20 2002-02-06 Univ Cambridge Tech Human antibodies and their use
EP1369128A1 (en) * 2002-06-07 2003-12-10 Procorde GmbH Inhibitors of glycoprotein VI and their therapeutic use
EP1647596A4 (en) * 2003-07-18 2008-02-13 Mochida Pharm Co Ltd Monoclonal antibody against platelet membrane glycoprotein vi
US7645592B2 (en) * 2004-04-29 2010-01-12 Otsuka Pharmaceutical Co., Ltd. Glycoprotein VI antibodies and methods of use thereof
CN1964990B (en) * 2004-04-29 2012-12-12 大冢制药株式会社 Antibodies specific for glycoprotein VI and methods of producing these antibodies
CA2606450A1 (en) * 2005-04-28 2006-11-09 Mochida Pharmaceutical Co., Ltd. Anti-platelet membrane glycoprotein vi monoclonal antibody

Also Published As

Publication number Publication date
CN101874107A (en) 2010-10-27
ZA201002990B (en) 2011-07-27
MX2010004537A (en) 2010-05-20
TW200936606A (en) 2009-09-01
JP2011502123A (en) 2011-01-20
CA2703770A1 (en) 2009-05-07
EP2212416A1 (en) 2010-08-04
EP2212416A4 (en) 2013-01-09
RU2010121878A (en) 2011-12-10
SG185307A1 (en) 2012-11-29
US20100297116A1 (en) 2010-11-25
KR20100075585A (en) 2010-07-02
IL205453A0 (en) 2010-12-30
AR069120A1 (en) 2009-12-30
AU2008319336A1 (en) 2009-05-07
WO2009058326A1 (en) 2009-05-07

Similar Documents

Publication Publication Date Title
BRPI0816318A2 (en) Transdermal delivery device, and method for preparing the same
BRPI0816349A2 (en) system, system for use in a well, and method
BRPI0813356A2 (en) PROTEIN KINASE INHIBITORS AND METHODS FOR THE SAME USE
DE602008003068D1 (en) Device connection, connection method and device therefor
BRPI0810201A2 (en) FLOOR MAINTENANCE TOOL AND METHOD.
DE602008000042D1 (en) Device for storing and sharpening knives
BRPI0920586A2 (en) separation device for use in the separation, characterization and / or identification of microorganisms.
ATE492363T1 (en) CUTTING TOOL AND CUTTING INSERT THEREOF
BRPI0821493A2 (en) Cutting insert and cutting tool
BR112012013247A2 (en) subsea set and method for use in subsea operations "
DE602007009863D1 (en) VERIFICABILITY PROCESS AND SAFETY ELEMENTS USED IN THE PROCESS
IL200632A0 (en) First aid system, procedure for its operation, and protable first-aid device for use especially in the system
BRPI0813828A2 (en) ANTIMICROBIAN COMPOUNDS, SUMMARY OF THE SAME AND THE USE OF THE SAME FOR THE TREATMENT OF INFECTIONS IN MAMMALS
BRPI0807476A2 (en) ELECTRONIC APPLIANCE, AND, TIE DETECTION METHOD FOR USE IN AN ELECTRONIC APPLIANCE.
EP2197319A4 (en) Adjustable armrest and method for the use thereof
BRPI0813778A2 (en) METHOD FOR FOOD SURFACING AND PASTEURIZATION.
BRPI0820413A2 (en) POLINUCLEOTIDES AND METHODS FOR PLANT IMPROVEMENT
BRPI0818807A2 (en) METHOD FOR INHIBITING REPERFUSION AND / OR COURSE INJURY IN A PATIENT NEEDING THE SAME AND USING A PLATTER GLYCOPROTEIN VI INHIBITOR
BRPI0509255A (en) purchasing device, method and machine for use thereof
EP2233258A4 (en) Blade member, and edge working apparatus for the blade member
ES1058474Y (en) PROTECTION RAIL FOR WORKS.
BRPI0819610A2 (en) POLINUCLEOTIDS AND METHODS FOR PLANT IMPROVEMENT
DE502006000768D1 (en) WINDSCHOTT FOR USE IN AIRPLANES
AT8531U3 (en) DEVICE FOR ELIMINATING UNRAT, IN PARTICULAR HUNDEKOT
ES1064715Y (en) PROTECTION DEVICE FOR STORES AND GARDENS IN WINDOWS.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2329 DE 25-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B15K Others concerning applications: alteration of classification

Ipc: C07K 16/28 (2006.01), A61K 39/00 (2006.01)

B350 Update of information on the portal [chapter 15.35 patent gazette]